Clinical trial
Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization…
NCT00387634 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00387634 |
|---|---|
| Title | Safety and Long-term Evaluation (up to 5 Years) of First Booster Immunization With Novartis' TBE Vaccine for Adults in Adolescents and Adults |
| Official title | A Phase IV, Uncontrolled, Open-label, Single-center Study in Adolescents and Adults: Evaluation of Immunogenicity and Safety of the First Booster Immunization With Novartis' TBE Vaccine for Adults in Participants of Study V48P7 and Long-term Evaluation of Immunogenicity up to 5 Years After First… |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tick Born Encephalitis |
| Intervention type | Biological |
| Interventions | TBE vaccine for adults |
| Enrollment | 323 |
| Start date | Sep 1, 2006 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Oct 13, 2006 |
| Last update posted | Nov 2, 2012 |
| Countries | Czechia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: